TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06471491

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Driving pressure-guided positive end-expiratory pressure
Description: Driving pressure-guided positive end-expiratory pressure during the surgical procedure
Study: NCT04754802

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PH94B Nasal Spray
Description: Nasal spray delivered 20 minutes before the public speaking stressor

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo Nasal Spray
Description: Nasal spray delivered 20 minutes before the public speaking stressor
Study: NCT04884061

Intervention type: OTHER
Intervention: NBI images and/or videos
Description: A library of NBI images and/or videos will be established from previously recorded bronchoscopies in 30 patients (10 with a SARS-CoV2 infection, 10 with a lower respiratory tract infection not related to SARS-CoV2, and 10 in patients with pulmonary nodule). NBI images and/or videos of the bronchial tree will then be analysed by three experimented interventional pulmonologists blinded to the patient ID. Each investigator will describe the vasculature pattern according to a prespecified grid: Normal mucosal vascularity / increased capillary density / presence of capillary loops / presence of dotted vessels / complex vascular networks of tortuous vessels or abrupt ending vessels / dilated longitudinal vessels. In case of discordance between the investigators, images will be reviewed to obtain a consensus.

Intervention type: OTHER
Intervention: NBI images and/or videos
Description: A library of NBI images and/or videos will be established from previously recorded bronchoscopies in 30 patients (10 with a SARS-CoV2 infection, 10 with a lower respiratory tract infection not related to SARS-CoV2, and 10 in patients with pulmonary nodule). NBI images and/or videos of the bronchial tree will then be analysed by three experimented interventional pulmonologists blinded to the patient ID. Each investigator will describe the vasculature pattern according to a prespecified grid: Normal mucosal vascularity / increased capillary density / presence of capillary loops / presence of dotted vessels / complex vascular networks of tortuous vessels or abrupt ending vessels / dilated longitudinal vessels. In case of discordance between the investigators, images will be reviewed to obtain a consensus.

Intervention type: OTHER
Intervention: NBI images and/or videos
Description: A library of NBI images and/or videos will be established from previously recorded bronchoscopies in 30 patients (10 with a SARS-CoV2 infection, 10 with a lower respiratory tract infection not related to SARS-CoV2, and 10 in patients with pulmonary nodule). NBI images and/or videos of the bronchial tree will then be analysed by three experimented interventional pulmonologists blinded to the patient ID. Each investigator will describe the vasculature pattern according to a prespecified grid: Normal mucosal vascularity / increased capillary density / presence of capillary loops / presence of dotted vessels / complex vascular networks of tortuous vessels or abrupt ending vessels / dilated longitudinal vessels. In case of discordance between the investigators, images will be reviewed to obtain a consensus.
Study: NCT05048641

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Whatsapp reminder
Description: Subjects who are allocated to the intervention group received reminder via WhatsApp Messenger at one month before the scheduled calendar month of biannual mammography follow-up.
Study: NCT06330519

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone sodium phosphate injection
Description: Patients receive 0.8ml of dexamethazone by periodontal ligament injection 30 minutes before the inferior alveolar nerve block

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: 1,1,1,2 tetrafluoroethane
Description: EndoIce (1,1,1,2 tetrafluoroethane) applied on the buccal, lingual (3 s/surface), and occlusal surfaces (4 s) for a total of 10 s then standard IANB was administered

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: intraoral soft tissue cryotherapy
Description: Small ice packs (wrapped in sterile gauze) placed intraorally in the mouth on the vestibular surface of the treated tooth for 5 minutes then standard IANB was administered
Study: NCT06011382

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Advanced Molar Distalization Appliance (amda®)
Description: AMDA is a prefabricated device anchored to the palate by miniscrews and it is a noncompliance appliance for maxillary molar distalization

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Buccal mini-implants
Description: Buccal mini-implants for maxillary molar distalization
Study: NCT04841330

Intervention type: DEVICE
Intervention: Securis™ Stabilization Device
Description: A trained clinician will apply and remove, and participants will wear the Securis™ Stabilization Device for up to one week (7 days) on their forearm. A shortened catheter will be placed (not inserted) over the Securis™ device in accordance with the product Information for Use (IFU), and an extension set attached to the catheter and secured in place, to simulate clinical use.
Study: NCT05767736

Intervention type: DRUG
Intervention: Diroximel Fumarate
Description: Administered as specified in the treatment arm.

Intervention type: DRUG
Intervention: Diroximel Fumarate
Description: Administered as specified in the treatment arm.

Intervention type: DRUG
Intervention: Dimethyl Fumarate
Description: Administered as specified in the treatment arm.

Intervention type: DRUG
Intervention: Dimethyl Fumarate
Description: Administered as specified in the treatment arm.
Study: NCT06406933

Intervention type: DRUG
Intervention: Carbomer Gel/Jelly
Description: The drug is for dry eye syndrome by providing temporary relief from discomfort and irritation.
Study: NCT05767736

Intervention type: DRUG
Intervention: Disease-Modifying Therapies (DMTs)
Description: Administered as specified in the treatment arm.
Study: NCT06110299

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: air injection
Description: delination of the ureter and pelvis by injecting air under C-ARM
Study: NCT06009224

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: ERAS perioperative management
Description: * Epidural analgesia~* Fluid balance~* Other items are the same as conventional
Study: NCT06760429

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Pectoral Nerve Block Type II
Description: In the PECS II group,once the needle tip reached the fascial plane between the pectoralis minor and serratus anterior muscles and there was no blood aspiration, 15 mL of 0.375% ropivacaine was injected. Then the needle was withdrawn until the needle tip reached the fascial plane between the pectoralis major and pectoralis minor muscles, and another 15 mL of 0.375% ropivacaine was injected. After the nerve block was implemented, the area of sensory block was marked, and the spread of the local anesthetic was monitored by ultrasound. Alcohol swabs and pinprick tests were used to detect cold and pain sensations.
Study: NCT06013605

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Walking Exercise and Leg Straightening
Description: Participants performed the exercise on the day agreed upon with the researcher. Respondents did walking exercises 3 times per week for 4 weeks with a duration of 10 minutes of warm-up, 30 minutes of walking exercises, and 10 minutes of cooling down. Respondents also did leg straightening every day for 4 weeks with a frequency of 1 time a day for 10 minutes.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Leg Straightening
Description: Respondents did leg straightening every day for 4 weeks with a frequency of 1 time a day for 10 minutes.
Study: NCT06361329

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Homoharringtonine
Description: Intravenous infusion

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: venetoclax
Description: Orally by mouth

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Cytarabine
Description: subcutaneous injection or Intravenous infusion

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cytarabine
Description: subcutaneous injection or Intravenous infusion

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: G-CSF
Description: subcutaneous injection

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Vindesine
Description: Intravenous infusion
Study: NCT06406933

Intervention type: DRUG
Intervention: Carbomer Gel/Jelly
Description: The drug is for dry eye syndrome by providing temporary relief from discomfort and irritation.

Intervention type: DRUG
Intervention: Carbomer Gel/Jelly
Description: The drug is for dry eye syndrome by providing temporary relief from discomfort and irritation.
Study: NCT05949593

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tinlarebant
Description: 5 mg tablet taken orally once a day

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo tablets for tinlarebant 5 mg prepared similarly.
Study: NCT05482022

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Shiley™ phonate speaking valve
Description: The device connects to the tracheostomy tube. Usually used to aid vocalization.

Intervention type: OTHER
Group type: OTHER
Intervention: control
Description: no intervention
Study: NCT06361329

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Daunorubicin
Description: Intravenous infusion

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: cyclophosphamide
Description: Intravenous infusion

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dexamethasone
Description: Intravenous infusion or orally

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: L-ASP
Description: subcutaneous injection
Study: NCT06053827

Intervention type: OTHER
Intervention: Frozen embryo transfer
Description: A frozen embryo transfer involves thawing a fertilized embryo and transferring it in the uterus in order to obtain a pregnancy

Intervention type: OTHER
Intervention: Frozen embryo transfer
Description: A frozen embryo transfer involves thawing a fertilized embryo and transferring it in the uterus in order to obtain a pregnancy
Study: NCT05328921

Intervention type: DRUG
Intervention: Antihypertensive Agents
Description: Patients with narrow angle glaucoma and on systemic antihypertensive drugs.

Intervention type: DRUG
Intervention: Antihypertensive Agents
Description: Patients with narrow angle glaucoma and on systemic antihypertensive drugs.

Intervention type: DRUG
Intervention: Antihistaminics
Description: Patients with narrow angle glaucoma and on systemic antihistaminic drugs.

Intervention type: DRUG
Intervention: Antihistaminics
Description: Patients with narrow angle glaucoma and on systemic antihistaminic drugs.
Study: NCT05947305

Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Surgical Blade
Description: Using a 15c blade to de-epithelialize the soft tissue extra-orally

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Mucotome
Description: Using Megagen Mucotome to de-epithelialize the soft tissue intra-orally

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Diamond Bur
Description: Using a surgical diamond bur to de-epithelialize the soft tissue intra-orally

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Er:YAG Laser
Description: Using an Er:YAG Laser to de-epithelialize the soft tissue intra-orally
Study: NCT05001269

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: nedosiran
Description: Monthly subcutaneous dosing throughout study period
Study: NCT06760429

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Subserratus Plane Block
Description: In the RISS group,the linear ultrasound probe was placed in the sagittal plane at the level of the 5th to 6th thoracic vertebrae (T5-6), just medial to the scapula, to identify the trapezius, rhomboid major, and intercostal muscles. A 21-gauge puncture needle was inserted in a cranial-to-caudal direction into the plane between the rhomboid major and intercostal muscles. When there was no blood aspiration, 20 mL of 0.375% ropivacaine was injected. After that, the ultrasound probe was moved caudally and laterally to identify the tissue plane between the serratus anterior and external intercostal muscles for performing the subserratus block at the level of the 8th to 9th thoracic vertebrae (T8-9). The puncture needle was advanced from the previous position, and when there was no blood aspiration again, an additional 20 mL of 0.375% ropivacaine was injected.
Study: NCT04881318

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Waist-High Compression Tights
Description: Waist-high compression tights providing 15-40 mmHg of pressure.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Waist-High Compression Tights
Description: Waist-high compression tights providing 15-40 mmHg of pressure.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Abdominal Compression Garments
Description: Abdominal compression garment compressing the abdomen, buttocks, and upper thighs.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Abdominal Compression Garments
Description: Abdominal compression garment compressing the abdomen, buttocks, and upper thighs.
Study: NCT06759883

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: local dishes using the my plate concept
Description: The intervention in this study consists of replacing the ready-to-use therapeutic foods prescribed in phase 2 of the management of acute severe malnutrition with balanced local dishes.
Study: NCT06759545

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dietary MOH recommendations and daily addition of 42 ml (three tablespoon) at each morning of EVOOEH
Description: Dietary intervention study: high-risk pregnant women receiving a link to MOH general dietary recommendations for pregnancy (MOH recommendations) with addition of three tablespoon (42 ml) EVOOEH (up to 0.8% free acidity) per day at each morning for four weeks during the first half of pregnancy (gestational ages between 8 to 16 weeks)

Intervention type: OTHER
Group type: OTHER
Intervention: Dietary MOH recommendations
Description: Dietary intervention study: high-risk pregnant women receiving a link to MOH general dietary recommendations for pregnancy (MOH recommendations) for four weeks during the first half of pregnancy (gestational ages between 8 to 16 weeks)
Study: NCT06759480

Intervention type: PROCEDURE
Intervention: Laparoscopic radical hysterectomy based on space anatomy
Description: This is a modified laparoscopic radical hysterectomy based on space anatomy. By identifying the vesicouterine ligament and four associated special spaces, the ureter can be completely liberated from the external aspect of the uterus. This skill not only reduces rate of surgical complications but also facilitates optimal tumor resection.

Intervention type: PROCEDURE
Intervention: Abdominal radical hysterectomy
Description: This producre is a classic and traditional radical hysterectomy.
Study: NCT06760494

Intervention type: DIAGNOSTIC_TEST
Intervention: the MAPUSE model
Description: Using the MAPUSE model to predict MVI status before surgical resection for HCC patients

Intervention type: DIAGNOSTIC_TEST
Intervention: the MAPUSE model
Description: Using the MAPUSE model to predict MVI status before surgical resection for HCC patients
Study: NCT06759376

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Vibration massage
Description: * Initiation of the stopwatch with the onset of intradialytic muscle cramp,~* Taking a salivary cortisol test,~* Performing vibration massage with a vibration massage device for 10 minutes,~* VAS questioning every 2 minutes during intradialytic muscle cramp,~* Stopping the stopwatch as soon as the patient states that the intradialytic muscle cramp has ended,~* Repeat salivary cortisol test at 20 minutes from the onset of intradialytic muscle cramp.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Static stretching exercise
Description: * Initiation of the stopwatch with the onset of intradialytic muscle cramp,~* Taking a salivary cortisol test,~* Perform static stretching exercise for 10 minutes,~* VAS questioning every 2 minutes during intradialytic muscle cramp,~* Stopping the stopwatch as soon as the patient states that the intradialytic muscle cramp has ended,~* Repeat salivary cortisol test at 20 minutes from the onset of intradialytic muscle cramp.

Intervention type: OTHER
Group type: OTHER
Intervention: Usual Care
Description: * Initiation of the stopwatch with the onset of intradialytic muscle cramp,~* Taking a salivary cortisol test,~* Usual care,~* VAS questioning every 2 minutes during intradialytic muscle cramp,~* Stopping the stopwatch as soon as the patient states that the intradialytic muscle cramp has ended,~* Repeat salivary cortisol test at 20 minutes from the onset of intradialytic muscle cramp.
Study: NCT06759740

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: 68Ga-DOTA-SEMA
Description: 68Ga-DOTA-SEMA is GLP1R imaging agent
Study: NCT06759363

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sodium-Butyrate
Description: 1000 mg/day of sodium-butyrate
Study: NCT04881318

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Medications that modulate heart rate and blood pressure
Description: Medications that modulate heart rate and blood pressure that participants regularly take. These medications include beta-blockers, midodrine, ivabradine and stimulants.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Medications that modulate heart rate and blood pressure
Description: Medications that modulate heart rate and blood pressure that participants regularly take. These medications include beta-blockers, midodrine, ivabradine and stimulants.
Study: NCT06759363

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Calcium Butyrate
Description: 1000 mg/day of calcium-butyrate
Study: NCT06760169

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Surgery with ELIOS laser
Description: This surgery involves visualizing the iridocorneal angle before or after cataract surgery, inserting the ELIOS laser probe into the anterior chamber to come into slight contact with the trabecular meshwork, then pressing the foot pedal, the surgeon activates the laser, which creates a microchannel by photoablating the trabecular meshwork and inner wall of Schlemm´s canal (trabeculostomy) ± 210 um in diameter. This gesture is repeated until 10 microchannels are created. The creation of these microchannels enhances the natural outflow of aqueous humor by bypassing the site of major resistance in the system. The usual duration of the ELIOS procedure is typically few minutes). The rest of the surgery does not deviate from standard phacoemulsification.
Study: NCT06760104

Intervention type: DIAGNOSTIC_TEST
Intervention: Dental Plaque Detection Using AI Models
Description: 1. AI Model Analysis:~   Description: Intraoral images of participants will be captured using standardized imaging techniques. These images will then be analyzed using various artificial intelligence models specifically designed for detecting dental plaque. The AI models will process the images to identify and quantify the presence of dental plaque.~2. Clinical Assessment:~Description: A qualified dentist will perform a traditional clinical examination of the participants to assess dental plaque using standard examination techniques. This will serve as the reference standard against which the AI models will be compared.~Study Procedures Image Acquisition: Intraoral images will be taken of each participant using \[ intraoral camera\].~AI Model Evaluation: The captured images will be analyzed using different AI algorithms, which may include.
Study: NCT06759155

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: de-intensified radiation
Description: Adjuvant radiation will be administered on a de-intensified schedule.

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: de-intensified radiation
Description: Adjuvant radiation will be administered on a de-intensified schedule.

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: de-intensified radiation
Description: Adjuvant radiation will be administered on a de-intensified schedule.
Study: NCT06759922

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tab Metformin + Tab Glimepiride
Description: Tab Metformin 500mg+ Tab Glimepiride 2mg (FDC) once per orally for 90 days.
Study: NCT05047341

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SHR0302、[14C]SHR0302
Description: 8 mg SHR0302/ 80 µCi \[14C\]SHR0302, once, D1
Study: NCT06002360

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Reach Out and Read
Description: Families will be provided with a book and ROR programming from trained study team members (either the principal investigator or a research assistant, both of whom are ROR trained). ROR programming will include discussion of current reading practices, anticipatory guidance on the importance and benefits of reading, modeling of active reading, discussion of how to incorporate reading into a daily routine and answering any questions parents/caregivers may have.
Study: NCT06009120

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Education
Description: The education program emphasized the characteristics of the oral stage, positive traits that can be acquired when the baby's needs are met during this stage, negative traits that may develop in the baby when their needs are not met, and the relationship between the oral stage and breastfeeding.
Study: NCT05455424

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Niraparib Oral Product
Description: Niraparib (\[3S\]-3-\[4-\[7-(aminocarbonyl)-2H-indazol-2-yl\] phenyl\] piperidine \[tosylate monohydrate salt\]) is an orally available, potent, and highly selective PARP1 and PARP2 inhibitor. The excipients for niraparib are lactose monohydrate and magnesium stearate. Niraparib will be supplied in bottles containing 72 capsules of 100 mg. The capsules should be swallowed whole with water. The capsules should not be chewed or crushed and can be taken without regard to meals.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Active Symptom Control
Description: ASC could involve regular specialist follow up; structured assessment of physical, psychological, and social problems; and appropriate treatment, including palliative radiotherapy and steroids.
Study: NCT06552702

Intervention type: OTHER
Intervention: There is no intervention
Description: There is no intervention.
Study: NCT04613024

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Topamax
Description: Experiment randomized group will be prescribed Topamax before and after surgery with follow up at regular interval

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Gabapentin
Description: Control group will be prescribed gabapentin after surgery with follow up at regular interval
Study: NCT06339489

Intervention type: DIAGNOSTIC_TEST
Intervention: Testing the serum levels of bone metabolic markers
Description: Testing serum levels of TRACP-5b and BALP, BMD values of lumbar spine L1-L4, left and right hip, left and right femoral neck et.al.